Company intelligence / Profile preview

NSite Medical

Palo Alto, California, USAcultivate-md.com ↗

Ownership: Private
Development stage: Commercial

Overview

NSite Medical has developed an FDA-cleared, AI-powered mobile application for scoliosis assessment. Clinical trials at Stanford and Duke demonstrated high accuracy in determining the presence, details, and severity of scoliosis. The technology aims to enable early detection, improve patient outcomes, reduce unnecessary surgeries, and lower healthcare costs associated with ineffective treatments.

Therapeutic areas: Other
Modalities: DeviceSoftware as a Medical Device (AI-based mobile app)
Industry: Digital Health Medical Devices

Partnerships

Early-stage partnerships with healthcare systems under development; specifics not disclosed yet

Beyond the preview

Go deeper on NSite Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSite Medical.

Explore the full profile